Standout Papers

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer... 2004 2026 2011 2018 1.4k
  1. Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2 (2004)
    Roy S. Herbst, Giuseppe Giaccone et al. Journal of Clinical Oncology
  2. Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials (2005)
    Daphne W. Bell, Thomas J. Lynch et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 27 from Science/Nature 114 standout
Sub-graph 1 of 14

Citing Papers

The biology and management of non-small cell lung cancer
2018 StandoutNature
Nanomaterials for Theranostics: Recent Advances and Future Challenges
2014 Standout
73 intermediate papers

Works of Annetta Krebs being referenced

Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials
2005 Standout
Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2
2004 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Annetta Krebs 1941 1849 122 709 8 2.7k
Lucie Lafontaine 1695 1153 80 1271 8 3.5k
Carol Peña 757 867 162 898 9 2.3k
Sofia Paul 1798 1872 42 458 24 2.7k
Katherine Liau 1082 833 66 858 36 2.0k
Ariel López-Chávez 2711 1853 138 805 41 3.6k
E. Roy Berger 2361 1889 673 960 10 4.3k
Yi Xu 2393 1719 641 959 7 4.1k
Michael Millward 1718 1123 139 1127 43 2.9k
Frauke Bentzien 657 510 76 805 12 2.0k
Vicki Goodman 1194 576 67 1105 24 2.3k

All Works

Loading papers...

Rankless by CCL
2026